NCT00163631View on ClinicalTrials.gov

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

CompletedOBSERVATIONAL
Timeline

Start Date

Not specified

Conditions
Portal Hypertension
Trial Locations (1)

3181

Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
lead

Bayside Health

OTHER_GOV

NCT00163631 - Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis | Biotech Hunter | Biotech Hunter